QIAGEN expands Germantown, Maryland manufacturing facility for COVID-19 testing

QIAGEN North American Holdings is expanding its US headquarters and R&D manufacturing facility in Germantown, Maryland, renovating its 146,000-square foot facility to expand production of COVID-19 and other disease testing products. The company has already added around 80 contracted staff and invested over $7 million.

“We are delighted to continue expanding our presence here in Germantown.”business.maryland.gov

• 1 source
• business.maryland.govQIAGEN continues growth in MarylandKaren Glenn HoodDec 11, 2020

Summarized from public sources; check the original articles before acting on it.